Month: April 2020

news_6

Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options

FETCROJA® (cefiderocol) has received European Commission (EC) marketing authorisation for the treatment of infections due to aerobic Gram-negative bacteria in...

news_6

Opportunity Analysis and Industry Forecast on the Baby Infant Formula Industry in the Asia-Pacific to 2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Baby Infant Formula Market by Type, Ingredient and Distribution Channel: Asia-Pacific Opportunity Analysis and Industry Forecast, 2019-2026"...